Early-stage firm applies microwave power to cancer tumors

Madison, Wis. - NeuWave Medical, a Madison-based medical device company that has landed $4.5 million in venture capital to further develop a microwave probe that destroys tumors, will try to capture a global market conservatively estimated at more than $200 million, according to one of its founding researchers. Daniel van der Weide, who developed the new microwave technology to ablate, or destroy cancerous tumors along with his University of Wisconsin-Madison colleague Fred T. Lee Jr, said there are a number of potential applications for the device, a minimally invasive microwave probe that is inserted into a patient like a needle to deliver microwaves that destroy tumors.

full article >> http://wistechnology.com/article.php?id=4529